GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (LTS:0Q4U) » Definitions » Total Current Assets

Novonesis (Novozymes) B (LTS:0Q4U) Total Current Assets : kr13,491 Mil (As of Jun. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Novonesis (Novozymes) B Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Novonesis (Novozymes) B's total current assets for the quarter that ended in Jun. 2024 was kr13,491 Mil.

Novonesis (Novozymes) B Total Current Assets Historical Data

The historical data trend for Novonesis (Novozymes) B's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Total Current Assets Chart

Novonesis (Novozymes) B Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,048.29 6,909.38 7,821.83 9,226.86 9,472.50

Novonesis (Novozymes) B Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,583.57 9,371.61 9,420.47 9,472.50 13,491.04

Novonesis (Novozymes) B Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Novonesis (Novozymes) B's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=1157.28+4055.496+3631.023+628.697
=9,472

Novonesis (Novozymes) B's Total Current Assets for the quarter that ended in Jun. 2024 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=1963.649+5976.778+5130.416+420.196
=13,491

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Novonesis (Novozymes) B  (LTS:0Q4U) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Novonesis (Novozymes) B's Liquidation Value for the quarter that ended in Jun. 2024 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1963.649-31699.016+0.75 * 5086.381+0.5 * 5130.416
=-23,355

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novonesis (Novozymes) B Total Current Assets Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis (Novozymes) B Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (LTS:0Q4U) » Definitions » Total Current Assets
Comparable Companies
OCSE:SPG OCSE:FLUG B OCSE:HOVE LIN XPAR:AI SHW ECL APD XSWX:SIKA ISX:TPIA XSWX:GIVN SHSE:600309 BOM:500820 DD XAMS:DSFIR PPG LYB IFF NSE:PIDILITIND ADX:BOROUGE
Traded in Other Exchanges
NVZMY:USA NVZMF:USA NSISBc:UK NSIS B:Denmark NZM2:Germany
Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Website
https://www.novozymes.com
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines